
PrivateFor profitVienna, Austria
Themis Bioscience is a start-up biotechnology company.
Size
11-50 people: larger than 33% of companies with a size listed
Age
17 years old.
Reach
No web traffic ranking listed.
BiotechnologyClinical TrialsHealth Care
Funding, as listed
$150M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Themis Bioscience, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Themis Bioscience may be growing as evidenced by a successful fundraising round where they raised €40M. This significant capital infusion suggests an expansion of financial resources, which can support ongoing research and development activities, particularly for their chikungunya vaccine. The ability to secure such funding indicates investor confidence in the company's potential and its projects within the biotechnology and health care industries.
Summaries written by the source dataset, not by us, and not checked.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 8,465 companies in Austria and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.